Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA

Size: px
Start display at page:

Download "Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA"

Transcription

1 Building Traceability for End Points in Analysis Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA 2010 Vertex Pharmaceuticals Incorporated

2 Outline Introduction: Traceability in ADaM Programming Introduction: SRCDOM, SRCVAR, and SRCSEQ Triplet Establishing Traceability in Sweat Chloride Analysis Dataset (ADSW) Using SRC Triplet Conclusion Questions/Comments/Thoughts 2

3 The Key Principles Of ADaM as Stated in ADaM IG v Analysis data should be analysis ready 2. Provide a level of traceability back to the input data 3

4 Introduction: What is Traceability? Per ADaM IG V1.0, The Property That Enables The Understanding Of Data Linkage And/Or the Relationship Between An Element And Its Predecessor (s) Two Levels Of Traceability 1. Metadata Traceability 2. Data Point Traceability 2010 Vertex Pharmaceuticals Incorporated

5 Metadata? Metadata: The Information About Data ADaM Programming Specification and Define.xml Provides Meta Data Traceability. 1. Programming Specification 2. Define.xml 2010 Vertex Pharmaceuticals Incorporated

6 Introduction: Data Point Traceability Enables the Users to Go Directly to the Specific Predecessor (s) Should Be Implemented If Practically Feasible Can Be Very Useful When A Reviewer Is Trying to Trace a Complex Manipulation Path Is Established by Providing Clear Links in the Data to the Data Specific Value Used As Input For Analysis Value May Not Always Practical or Feasible to Provide Data-point Traceability Via Record-identifier Variables From Source Dataset (s) 2010 Vertex Pharmaceuticals Incorporated

7 How To Build Data Point Traceability? (I) ADaM IG V1.0 recommends numerous ways to build Data Point Traceability. Few Examples: 1. Inclusion of a supportive row or column for traceability even if not required for analysis (VISIT, --SEQ.) 2. PARAMTYP= DERIVED 3. Populating variable DTYPE with derivation method 7

8 How To Build Data Point Traceability? (II) 4. Populating ANLxxFL to support the accurate selection of records for analysis 5. CRITy/CRITyFL/CRITyFN variables to define and detect the presence of a criterion 6. Combine the Triplet of SRCDOM, SRCVAR, and SRCSEQ with Derived Variables in ADaM IG 1.0 in Page 38 8

9 Goal to Build Traceability in ADaM Data 1. Facilitate Transparency 2. Build Confidence in Analysis Results 3. Facilitate Programming Validation 4. Speed Up the Overall Review Process from FDA Reviewers 5. Build A Good Relationship with FDA Reviewers Vertex Pharmaceuticals Incorporated

10 Definition: Using Triplet: SRCDOM, SRCVAR, and SRCSEQ to Build Traceability (I) SRCDOM Source Domain The 2-character identifier of the SDTM domain that relates to AVAL or AVALC. SRCVAR Source Variable The name of the column (in the SDTM domain identified by SRCDOM) that relates to AVAL or AVALC. SRCSEQ Source Sequence Number The sequence number SEQ of the row (in the SDTM domain identified by SRCDOM) that relates to AVAL or AVALC Vertex Pharmaceuticals Incorporated

11 Definition: Using Triplet: SRCDOM, SRCVAR, and SRCSEQ to Build Traceability (II) Per the definition from ADaM IG V SRCDOM should be a SDTM domain. 2. SRCVAR should be a variable from SDTM domain. 3. SRCSEQ should be a SEQ from SDTM domain. 11

12 Limitation Of SRCDOM, SRCVAR, and SRCSEQ Limitation of the Triplet : One Source SDTM Domain One Source Record One Source Variable Only Direct Copy of Source Value Can NOT Keep Traceability When An Analysis Parameter in ADaM Is Derived from Multiple SDTM Records. 12

13 Solutions to the Limitation This presentation provides examples of using SRC--- triplet to resolve this limitation by slightly modifying the usage of SRC--- triplet without losing the actual definition. Use Another Method Shown in the Next Slide 13

14 Another Method: Adding Variable Pair : RLCRIT and RLFACT Use Metadata to Describe the Derivation Rules of the Derived Parameters Add Variables RLCRIT and RLFACT to Connect Derived Records and Their Source Records: RLCRIT - relation criteria that stores data source (ADaM or SDTM data sets) with source variables in order RLFACT - relation factors that stores the values of those source variables in the same order Refer to 1. Zhu, Songhui and Yan, Lin. Methods of Building Traceability for ADaM Data. PharmaSUG Xiangchen (Bob) Cui, Hongyu Liu, and Tathabbai Pakalapati. Examples of Building Traceability in CDISC ADaM Datasets for FDA Submission. SAS Global, April Vertex Pharmaceuticals Incorporated

15 Introduction In this presentation, the examples were from efficacy ADaM datasets from Cystic Fibrosis therapeutic area. We will discuss ADSW (Sweat Chloride Analysis Data Set) today. 15

16 Structure of Sweat Chloride of SDTM.SW Note: Records with even numbers of swseq were from the volume and the records with odd numbers of swseq were used for analysis. 16

17 Analysis Value of Sweat Chloride (ADSW.AVAL) at An Analysis Visit (AVISIT) in ADaM Per SAP 1. Analysis Value at Each Analysis Visit (AVISIT): Average of Sweat Chloride at Both Left and Right Arms Collected at A Nominal Visit 2. Baseline Analysis Visit: Average of Sweat Chloride from the Pre-dose Scheduled Visits 3. Average On-treatment Sweat Chloride: Average of Sweat Chloride from the On-treatment Scheduled Visits Note: 2 and 3 are the Average of analysis values from 1, i.e. values from ADaM.ADSW, not SDTM.SW. 17

18 Building Data Point Traceability for These Three Averages in ADSW Create Variable ASWSEQ= Analysis Sequence Number Starting from 1000 to Indicate the Newly Created Records PARAMTYP= DERIVED DTYPE= AVERAGE Populate the Variable SRCDOM, SRCVAR, and SRCSEQ to These Newly Created Records 18

19 Traceability For Average Sweat Chloride At Both Left And Right Arms At Every Analysis Visit 1. PARAMTYP= DERIVED tells the reviewer these records are derived in ADaM, with sequence numbers above SRCSEQ=23 for AVISIT= Day 14 suggests that only sweat chloride at left arm is used to populate AVAL, as sweat chloride at right arm is missing SRCSEQ lists sequence numbers, separated by $, of those records in SDTM SW used in deriving AVAL. Hence SRCSEQ is the concatenation of two sequence numbers--- A deviation from IG!

20 Traceability For Baseline Analysis Visit (I) ASWSEQ = 0.5 more than the sequence number corresponding to the last predose analysis visit ( ) to be created as a new sorting key in ADSW SRCDOM= ADSW, SRCVAR= AVAL and SRCSEQ= 1001$1002 for AVISIT= Baseline indicating that analysis value (AVAL) is derived, using the AVAL in ADSW, corresponding to sequence numbers 1001 and 1002 (Screening and Day 1 visit, respectively). SRC-triplet above shows another deviation from ADaM IG! 20

21 Traceability For Average On-Treatment Sweat Chloride Defined as the average of on-treatment analysis values (Day 7, 14, 21, and 28) Its calculation is same as one from Baseline Analysis Visit for traceability with SRCDOM=ADSW and SRCVAR=AVAL. 21

22 An Example of Traceability For Average On- Treatment Sweat Chloride (I) 22

23 An Example of Traceability For Average On- Treatment Sweat Chloride (II) How About We Change SRCSEQ= 1005$1006$1007$1008 into More Meaningful SRCSEQ= DAY 7$DAY 14$DAY 21$DAY 28? Better communication and reviewing of the data records 23

24 An Example of Traceability For Average On- Treatment Sweat Chloride (III) SRCSEQ= DAY 7$DAY 14$DAY 21$DAY 28 SRCSEQ is from VISIT, not ASWSEQ anymore! No sequence numbers are involved! A severe deviation from ADaM IG! 24

25 An Example of Traceability For Average On- Treatment Sweat Chloride (III) 25

26 An Example of Traceability For Average On- Treatment Sweat Chloride (I) 26

27 Snapshot of Traceability For Average On-Treatment Sweat Chloride for Multiple Subjects (I) 27

28 How Much To Pay For Traceability? No Free Lunch! Write A Clear ADaM Programming Specification Extra SAS Codes 2010 Vertex Pharmaceuticals Incorporated

29 Write A Clear ADaM Programming Specification Variable Name Variable Label Type Length Controlled Terms or Formats Origin Role Comments Core SRCDOM Source Domain Char 4 Derived Analysis Equal to "ADSW" for derived records (PARAMTYP="DERIVED") and AVISIT is equal to "Baseline" or "Average through Day 28" Equal to "SW" for all other derived records (PARAMTYP ="DERIVED") SRCVAR SRCSEQ Source Variable Source Sequence Number Char 8 Derived Analysis Equal to "AVAL" for derived records (PARAMTYP ="DERIVED") where AVISIT is equal to "Baseline" Equal to "AVAL" for derived records (PARAMTYP ="DERIVED") where AVISIT is equal to "Average through Day 28" Equal to "SWSTRESN" for all other derived records (PARAMTYP="DERIVED") Char 40 Derived Analysis For AVISIT="Baseline" SRCSEQ lists the sequence numbers (SW.SWSEQ) of records that are used to derive the analysis baseline value. Example: if sequence numbers of Screening and Day 1 are 1 and 2 respectively, then SRCSEQ is equal to 1$2 For AVISIT="Average through Day 28" SRCSEQ lists the analysis visits (ADSW.AVISIT) of records that are used to derive the analysis value (average of Day 7, Day 14, Day 21, Day 28). Example: if Day 7, Day 14, Day 21, Day 28 are used to drive the average then SRCSEQ is equal to Day 7$Day 14$Day 21$Day 28 For other derived records SRCSEQ lists the sequence numbers (SW.SWSEQ) of records used to derive the analysis value at each analysis visit. Example: if sequence numbers of SW_CL_L and SW_CL_R at Day 7 are 4 and 5 respectively, then SRCSEQ is equal to 4$5 for AVISIT=DAY 7 Perm Perm Perm 29

30 Extra SAS Codes for Average On-Treatment: Highlighted in Red Color *** calculate average day 1 through day 28 ( average day 7, 14, 21, and 28 by nominal visit regardless on safety follow up records; proc sort data = sw_cl_m2 out=for_avg; by usubjid swtestcd ADTM visitnum swseq; where visit in ('DAY 7','DAY 14','DAY 21') or (visit='day 28' and SWTPTNUM<=0); run; data average; length DTYPE $20. SRCSEQ $40. SRCDOM $4. SRCVAR $8.; retain total nobs 0 SRCSEQ ''; set for_avg(drop=srcseq); by usubjid SWTESTCD ADTM visitnum; if first.swtestcd then do; total=swstresn; nobs=1; SRCSEQ=strip(visit);end; else do;total=total+swstresn; nobs=nobs+1; SRCSEQ=strip(SRCSEQ) "$" strip(visit); end; if last.swtestcd then do; DTYPE='AVERAGE'; SWSTRESN=total/nobs; SWSEQ=SWSEQ+0.5; SRCDOM='ADSW'; SRCVAR='AVAL'; output; end; run; 30

31 Is it legal? Is it CDISC ADaM compliant? CDISC ADaM Validation Checks Version 1.2 Rule 180 out of 243 Rules: Only SRCDOM It is illegal! 31

32 Will We Get Caught Out! We uploaded All ADaM datasets from the study into OpenCDISC Validator for Compliance Checking. No Errors or Warning Messages Reported for SRC-triplet! 32

33 Will We Get Caught Out! Cont ed OpenCDISC Validator implements total 130 rules from CDISC ADaM Validation Checks Version 1.2 with total 243 rules. OpenCDISC Validator Website: The following is a listing of CDISC ADaM version 1.0 validation rules implemented in OpenCDISC Validator. The rules are based on the validation checks published by CDISC ADaM team. 33

34 Snapshot of OpenCDISC Validator ADaM Validation Rules from Its Web Site 34

35 Is it legal? Cont ed Rule 180 Has NOT Been Applied in OpenCDISC Validator Yet. OpenCDISC Validator Can Not Catch It! It seems that we are lucky. 35

36 The Key Message Here: Should the rule 180 be relaxed into the inclusion of a ADaM domain, in addition to single SDTM domain? Should CDISC ADaM Team Consider to Modify the Rule for SRC-Triplet? 1. SRCDOM: both a SDTM domain and a ADaM domain 2. SRCVAR: both a SDTM Variable and a ADaM Variable 3. SRCSEQ: single SDTM sequence number, multiple SDTM sequence numbers, and other variables 36

37 Conclusion Incorporating traceability features in ADaM datasets: Helps in effective program validation Speeds up the review process Transparency in submitted analysis data Good Relationship with FDA Applying SRCDOM, SRCVAR, and SRCSEQ to establish traceability is an Art, not a Rocket Science. CDISC ADaM Team Should consider to modify the rule for SRC-Triplet in order to better establishing traceability in ADaM programming! 37

38 Questions / Comments / Thoughts Vertex Pharmaceuticals Incorporated

PharmaSUG DS05

PharmaSUG DS05 PharmaSUG 2013 - DS05 Building Traceability for End Points in Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen Cui, Vertex Pharmaceuticals Incorporated Tathabbai Pakalapati, Cytel Inc. Qunming

More information

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission PharmaSUG 2017 - Paper SS03 Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission ABSTRACT Tianshu Li, Celldex Therapeutics, Hampton, NJ Traceability is one of the

More information

Traceability Look for the source of your analysis results

Traceability Look for the source of your analysis results Traceability Look for the source of your analysis results Herman Ament, Cromsource CDISC UG Milan 21 October 2016 Contents Introduction, history and CDISC Traceability Examples Conclusion 2 / 24 Introduction,

More information

Introduction to ADaM and What s new in ADaM

Introduction to ADaM and What s new in ADaM Introduction to ADaM and What s new in ADaM Italian CDISC UN Day - Milan 27 th October 2017 Silvia Faini Principal Statistical Programmer CROS NT - Verona ADaM Purpose Why are standards needed in analysis

More information

Applying ADaM Principles in Developing a Response Analysis Dataset

Applying ADaM Principles in Developing a Response Analysis Dataset PharmaSUG2010 Paper CD03 Applying ADaM Principles in Developing a Response Analysis Dataset Mei Dey, Merck & Co., Inc Lisa Pyle, Merck & Co., Inc ABSTRACT The Clinical Data Interchange Standards Consortium

More information

Introduction to ADaM standards

Introduction to ADaM standards Introduction to ADaM standards Elke Sennewald, Director Biostatistics EU/AP, 06 March 2009 1 Outline ADaM Version 2.0 / 2.1 General Considerations ADaM draft Version 2.1 ADaMIG draft Version 1.0 ADaM Variables

More information

ADaM and traceability: Chiesi experience

ADaM and traceability: Chiesi experience ADaM and traceability: Chiesi experience BIAS Seminar «Data handling and reporting in clinical trials with SAS» Glauco Cappellini 22-Feb-2013 Agenda Chiesi Model for Biometrics Regulatory Background ADaM:

More information

ADaM for Medical Devices: Extending the Current ADaM Structures

ADaM for Medical Devices: Extending the Current ADaM Structures PharmaSUG 2018 - Paper MD-02 ADaM for Medical s: Extending the Current ADaM Structures Sandra Minjoe, PRA Health Sciences; Julia Yang, Medtronic PLC; Priya Gopal, TESARO, Inc. ABSTRACT The current ADaM

More information

Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA

Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA ABSTRACT PharmaSUG 2013 - Paper PO13 Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA Traceability is one of the fundamentals of the ADaM Standard. However, there is not

More information

PharmaSUG Paper PO22

PharmaSUG Paper PO22 PharmaSUG 2015 - Paper PO22 Challenges in Developing ADSL with Baseline Data Hongyu Liu, Vertex Pharmaceuticals Incorporated, Boston, MA Hang Pang, Vertex Pharmaceuticals Incorporated, Boston, MA ABSTRACT

More information

An Efficient Solution to Efficacy ADaM Design and Implementation

An Efficient Solution to Efficacy ADaM Design and Implementation PharmaSUG 2017 - Paper AD05 An Efficient Solution to Efficacy ADaM Design and Implementation Chengxin Li, Pfizer Consumer Healthcare, Madison, NJ, USA Zhongwei Zhou, Pfizer Consumer Healthcare, Madison,

More information

PharmaSUG2014 Paper DS09

PharmaSUG2014 Paper DS09 PharmaSUG2014 Paper DS09 An ADaM Interim Dataset for Time-to-Event Analysis Needs Tom Santopoli, Accenture, Berwyn, PA Kim Minkalis, Accenture, Berwyn, PA Sandra Minjoe, Accenture, Berwyn, PA ABSTRACT

More information

Programming checks: Reviewing the overall quality of the deliverables without parallel programming

Programming checks: Reviewing the overall quality of the deliverables without parallel programming PharmaSUG 2016 Paper IB04 Programming checks: Reviewing the overall quality of the deliverables without parallel programming Shailendra Phadke, Baxalta US Inc., Cambridge MA Veronika Csom, Baxalta US Inc.,

More information

Riepilogo e Spazio Q&A

Riepilogo e Spazio Q&A Riepilogo e Spazio Q&A CDISC Italian User Network Day 27 Ottobre 2017 Angelo Tinazzi (Cytel) - Silvia Faini (CROS NT) E3C members 2 Agenda ADaM key list Bad & Good ADaM...More... Spazio Q&A ADaM Key List

More information

ADaM Compliance Starts with ADaM Specifications

ADaM Compliance Starts with ADaM Specifications PharmaSUG 2017 - Paper DS16 ADaM Compliance Starts with ADaM Specifications Trevor Mankus, Kent Letourneau, PRA Health Sciences ABSTRACT As of December 17th, 2016, the FDA and PMDA require that all new

More information

How to write ADaM specifications like a ninja.

How to write ADaM specifications like a ninja. Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation

More information

PharmaSUG Paper CC02

PharmaSUG Paper CC02 PharmaSUG 2012 - Paper CC02 Automatic Version Control and Track Changes of CDISC ADaM Specifications for FDA Submission Xiangchen (Bob) Cui, Vertex Pharmaceuticals, Cambridge, MA Min Chen, Vertex Pharmaceuticals,

More information

Automate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.

Automate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc. Automate Analysis Results Metadata in the Define-XML v2.0 Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc., USA 1 Topics Introduction Analysis Results Metadata (ARM) Version 1.0 o o

More information

ADaM Implementation Guide Prepared by the CDISC ADaM Team

ADaM Implementation Guide Prepared by the CDISC ADaM Team 1 2 3 ADaM Implementation Guide Prepared by the CDISC ADaM Team 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Revision History Notes to Readers Date Version Summary of Changes May 30, 2008 1.0 Draft

More information

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA PharmaSUG 2013 - Paper DS06 Designing and Tuning ADaM Datasets Songhui ZHU, K&L Consulting Services, Fort Washington, PA ABSTRACT The developers/authors of CDISC ADaM Model and ADaM IG made enormous effort

More information

A Taste of SDTM in Real Time

A Taste of SDTM in Real Time A Taste of SDTM in Real Time Changhong Shi, Merck & Co., Inc., Rahway, NJ Beilei Xu, Merck & Co., Inc., Rahway, NJ ABSTRACT The Study Data Tabulation Model (SDTM) is a Clinical Data Interchange Standards

More information

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets PharmaSUG 2017 - Paper SS09 Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets Xiangchen (Bob) Cui, Min Chen, and Letan (Cleo) Lin, Alkermes Inc.,

More information

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA PharmaSug2016- Paper HA03 Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA ABSTRACT A composite endpoint in a Randomized Clinical Trial

More information

Creating an ADaM Data Set for Correlation Analyses

Creating an ADaM Data Set for Correlation Analyses PharmaSUG 2018 - Paper DS-17 ABSTRACT Creating an ADaM Data Set for Correlation Analyses Chad Melson, Experis Clinical, Cincinnati, OH The purpose of a correlation analysis is to evaluate relationships

More information

Leveraging ADaM Principles to Make Analysis Database and Table Programming More Efficient Andrew L Hulme, PPD, Kansas City, MO

Leveraging ADaM Principles to Make Analysis Database and Table Programming More Efficient Andrew L Hulme, PPD, Kansas City, MO PharmaSUG 2015 - Paper PO13 Leveraging ADaM Principles to Make Analysis Database and Table Programming More Efficient Andrew L Hulme, PPD, Kansas City, MO ABSTRACT The purpose of the CDISC Analysis Data

More information

Optimization of the traceability when applying an ADaM Parallel Conversion Method

Optimization of the traceability when applying an ADaM Parallel Conversion Method SI04 Optimization of the traceability when applying an ADaM Parallel Conversion Method Roxane Debrus ADaM Conversion Process Agenda %LIB_QC_contents_html %adam_sdtm_compa Conclusion ADaM Conversion Process

More information

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA PharmaSUG 2017 - Paper DS23 The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA ABSTRACT Since FDA released the Analysis

More information

Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes!

Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes! 1 Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes! The ADaM documentation provides examples of many of

More information

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity John Brega Linda Collins PharmaStat LLC Topics Part 1: A Standard with Many Uses Status of the Define.xml Standard

More information

ADaM Implementation Guide Status Update

ADaM Implementation Guide Status Update ADaM Implementation Guide Status Update John K. Troxell John Troxell Consulting LLC Bridgewater, NJ jktroxell@gmail.com June 17, 2013 Current CDISC ADaM Documents 2009 Analysis Data Model (ADaM), Version

More information

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development PharmaSUG 2018 - Paper DS-15 Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development Aakar Shah, Pfizer Inc; Tracy Sherman, Ephicacy Consulting Group, Inc.

More information

Dealing with changing versions of SDTM and Controlled Terminology (CT)

Dealing with changing versions of SDTM and Controlled Terminology (CT) CDISC UK Network Breakout session Notes 07/06/16 Afternoon Session 1: Dealing with changing versions of SDTM and Controlled Terminology (CT) How do people manage this? Is this managed via a sponsor Standards

More information

PharmaSUG Paper DS-24. Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP

PharmaSUG Paper DS-24. Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP PharmaSUG 2018 - Paper DS-24 Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP Kamlesh Patel, Rang Technologies Inc, New Jersey Jigar Patel, Rang Technologies Inc, New Jersey Dilip Patel,

More information

PharmaSUG Paper DS24

PharmaSUG Paper DS24 PharmaSUG 2017 - Paper DS24 ADQRS: Basic Principles for Building Questionnaire, Rating and Scale Datasets Nancy Brucken, inventiv Health, Ann Arbor, MI Karin LaPann, Shire, Lexington, MA ABSTRACT Questionnaires,

More information

Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop

Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop Taming the SHREW SDTM Heuristic Research and Evaluation Workshop September 13, 2013 Carlo Radovsky 2 Overview Introductions The Backstory CDISC IntraChange History of a Rule The Challenge Discuss Amongst

More information

OpenCDISC Validator 1.4 What s New?

OpenCDISC Validator 1.4 What s New? OpenCDISC Validator 1.4 What s New? Bay Area CDISC Implementation Network 23 May 2013 David Borbas Sr Director, Data Management Jazz Pharmaceuticals, Inc. Disclaimers The opinions expressed in this presentation

More information

Optimization of the traceability when applying an ADaM Parallel Conversion Method

Optimization of the traceability when applying an ADaM Parallel Conversion Method Paper SI04 Optimization of the traceability when applying an ADaM Parallel Conversion Method DEBRUS Roxane, Business & Decision Life Sciences, Brussels, Belgium ABSTRACT One of the methods to create CDISC

More information

ADaM Reviewer s Guide Interpretation and Implementation

ADaM Reviewer s Guide Interpretation and Implementation Paper CD13 ADaM Reviewer s Guide Interpretation and Implementation Steve Griffiths, GlaxoSmithKline, Stockley Park, UK ABSTRACT Throughout the course of a study, teams will make a lot of decisions about

More information

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples PharmaSUG 2017 - Paper DS06 Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples Keith Shusterman, Chiltern; Prathima Surabhi, AstraZeneca; Binoy Varghese, Medimmune ABSTRACT

More information

Traceability: Some Thoughts and Examples for ADaM Needs

Traceability: Some Thoughts and Examples for ADaM Needs PharmaSUG 2018 - Paper DS-01 Traceability: Some Thoughts and Examples for ADaM Needs Sandra Minjoe, PRA Health Sciences; Wayne Zhong, Accretion Softworks; Quan (Jenny) Zhou, Eli Lilly and Company; Kent

More information

DIA 11234: CDER Data Standards Common Issues Document webinar questions

DIA 11234: CDER Data Standards Common Issues Document webinar questions Q: What is the preferred data definition format for ADaM analysis data, define.xml or define.pdf? 1 ADaM Define File Q: The CRTDDS does not describe how to submit a define.xml for ADaM. Does CDER expect

More information

NCI/CDISC or User Specified CT

NCI/CDISC or User Specified CT NCI/CDISC or User Specified CT Q: When to specify CT? CT should be provided for every variable with a finite set of valid values (e.g., the variable AESEV in ADAE can have the values MILD, MODERATE or

More information

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat PharmaSUG Single Day Event San Francisco Bay Area 2015-02-10 What is the Computational Sciences Symposium? CSS originally formed to help FDA

More information

What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting

What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting

More information

An Introduction to Visit Window Challenges and Solutions

An Introduction to Visit Window Challenges and Solutions ABSTRACT Paper 125-2017 An Introduction to Visit Window Challenges and Solutions Mai Ngo, SynteractHCR In clinical trial studies, statistical programmers often face the challenge of subjects visits not

More information

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments... From Implementing CDISC Using SAS. Full book available for purchase here. Contents About This Book... xi About The Authors... xvii Acknowledgments... xix Chapter 1: Implementation Strategies... 1 Why CDISC

More information

Interpreting CDISC ADaM IG through Users Interpretation

Interpreting CDISC ADaM IG through Users Interpretation Paper CD01 Interpreting CDISC ADaM IG through Users Interpretation Angelo Tinazzi, Cytel Inc., Geneva, Switzerland ABSTRACT It is now almost three years CDISC ADaM is an official standard the pharmaceutical

More information

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 PharmaSUG 2018 - Paper SS-15 It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 ABSTRACT Supriya Davuluri, PPD, LLC, Morrisville, NC There are some obvious challenges

More information

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on DCDISC Users Group Nate Freimark Omnicare Clinical Research Presented on 2011-05-12 1 Disclaimer The opinions provided are solely those of the author and not those of the ADaM team or Omnicare Clinical

More information

Customer oriented CDISC implementation

Customer oriented CDISC implementation Paper CD10 Customer oriented CDISC implementation Edelbert Arnold, Accovion GmbH, Eschborn, Germany Ulrike Plank, Accovion GmbH, Eschborn, Germany ABSTRACT The Clinical Data Interchange Standards Consortium

More information

Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation

Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation ABSTRACT Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation Richann Watson, Experis, Batavia, OH Karl Miller, inventiv Health, Lincoln, NE The ADaM Implementation Guide was created

More information

Out-of-the-box %definexml

Out-of-the-box %definexml Out-of-the-box %definexml Just a Simple SAS Macro PhUSE / October 2016 / Katja Glaß Agenda Introduction Getting Started %DefineXML Collaborate Summary Page 2 DefineXML Katja Glaß 11. October 2016 Introduction

More information

Material covered in the Dec 2014 FDA Binding Guidances

Material covered in the Dec 2014 FDA Binding Guidances Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes Sandra Minjoe Senior ADaM Consultant Preparing ADaM and Related Files for Submission Presentation Focus Material

More information

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method PharmaSUG 2015 - Paper AD01 The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method Chengxin Li, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA ABSTRACT

More information

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India Paper CD15 PhUSE 2016 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences,

More information

Deriving Rows in CDISC ADaM BDS Datasets

Deriving Rows in CDISC ADaM BDS Datasets ABSTRACT PharmaSUG 2017 Paper DS22 Deriving Rows in CDISC ADaM BDS Datasets Sandra Minjoe, Accenture Accelerated R&D Services The ADaM Basic Data Structure (BDS) can be used for many analysis needs, including

More information

Updates on CDISC Standards Validation

Updates on CDISC Standards Validation Updates on CDISC Standards Validation NJ CDISC User Group September 19, 2013 Topics CDISC standards validation initiative FDA update on SEND checks OpenCDISC v1.4.1 release OpenCDISC plans 2 CDISC validation

More information

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania PharmaSUG 2013 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis

More information

Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets

Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets PharmaSUG2011 Paper CD17 Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets Elizabeth Li, PharmaStat LLC, Newark, California Linda Collins, PharmaStat

More information

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components PharmaSUG 2017 - Paper AD19 SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components Walter Hufford, Vincent Guo, and Mijun Hu, Novartis Pharmaceuticals Corporation ABSTRACT

More information

Some Considerations When Designing ADaM Datasets

Some Considerations When Designing ADaM Datasets Some Considerations When Designing ADaM Datasets Italian CDISC UN Day - Milan 27 th October 2017 Antonio Valenti Principal Statistical Programmer CROS NT - Verona Content Disclaimer All content included

More information

PhUSE US Connect 2019

PhUSE US Connect 2019 PhUSE US Connect 2019 Paper SI04 Creation of ADaM Define.xml v2.0 Using SAS Program and Pinnacle 21 Yan Lei, Johnson & Johnson, Spring House, PA, USA Yongjiang Xu, Johnson & Johnson, Spring House, PA,

More information

Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1

Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1 PharmaSUG 2017 - Paper DS18 Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1 John Troxell, Accenture ABSTRACT Since the publication of version 1.0 of the CDISC (Clinical Data Interchange

More information

esubmission - Are you really Compliant?

esubmission - Are you really Compliant? ABSTRACT PharmaSUG 2018 - Paper SS21 esubmission - Are you really Compliant? Majdoub Haloui, Merck & Co., Inc., Upper Gwynedd, PA, USA Suhas R. Sanjee, Merck & Co., Inc., Upper Gwynedd, PA, USA Pinnacle

More information

How to handle different versions of SDTM & DEFINE generation in a Single Study?

How to handle different versions of SDTM & DEFINE generation in a Single Study? Paper CD15 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai,

More information

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library PharmaSUG 2018 - Paper SS-12 Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library Veena Nataraj, Erica Davis, Shire ABSTRACT Establishing internal Data Standards helps companies

More information

Common Programming Errors in CDISC Data

Common Programming Errors in CDISC Data ABSTRACT PharmaSUG 2017 - Paper DS15 Common Programming Errors in CDISC Data Sergiy Sirichenko, Pinnacle 21 Data in standardized format is now a required part of regulatory submissions. CDISC standards

More information

SDTM-ETL 3.0 User Manual and Tutorial

SDTM-ETL 3.0 User Manual and Tutorial SDTM-ETL 3.0 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2014-03-29 Creating mappings for the SV (Subject Visits) domain Although Fred Wood, one of the authors of the SDTM Implementation

More information

Lex Jansen Octagon Research Solutions, Inc.

Lex Jansen Octagon Research Solutions, Inc. Converting the define.xml to a Relational Database to enable Printing and Validation Lex Jansen Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D PhUSE 2009, Basel,

More information

From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI

From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI PharmaSUG2011 - Paper HW05 From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI ABSTRACT You've just read through the protocol,

More information

Considerations on creation of SDTM datasets for extended studies

Considerations on creation of SDTM datasets for extended studies 13/May/2016 As one of the activities of CDISC Japan User Group (CJUG), a small group, "Extension study team" was organized in 2015. The team discussed what kind of approach works better for SDTM creation

More information

Automation of SDTM Programming in Oncology Disease Response Domain Yiwen Wang, Yu Cheng, Ju Chen Eli Lilly and Company, China

Automation of SDTM Programming in Oncology Disease Response Domain Yiwen Wang, Yu Cheng, Ju Chen Eli Lilly and Company, China ABSTRACT Study Data Tabulation Model (SDTM) is an evolving global standard which is widely used for regulatory submissions. The automation of SDTM programming is essential to maximize the programming efficiency

More information

Why organizations need MDR system to manage clinical metadata?

Why organizations need MDR system to manage clinical metadata? PharmaSUG 2018 - Paper SS-17 Why organizations need MDR system to manage clinical metadata? Abhinav Jain, Ephicacy Consulting Group Inc. ABSTRACT In the last decade, CDISC standards undoubtedly have transformed

More information

PharmaSUG Paper PO21

PharmaSUG Paper PO21 PharmaSUG 2015 - Paper PO21 Evaluating SDTM SUPP Domain For AdaM - Trash Can Or Buried Treasure Xiaopeng Li, Celerion, Lincoln, NE Yi Liu, Celerion, Lincoln, NE Chun Feng, Celerion, Lincoln, NE ABSTRACT

More information

SDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6

SDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6 SDTM-ETL TM New features in version 1.6 Author: Jozef Aerts XML4Pharma July 2011 p.1/14 Table of Contents Implementation of SEND v.3.0 final...3 Automated creation of the RELREC dataset and records...4

More information

Standardizing FDA Data to Improve Success in Pediatric Drug Development

Standardizing FDA Data to Improve Success in Pediatric Drug Development Paper RA01 Standardizing FDA Data to Improve Success in Pediatric Drug Development Case Study: Harmonizing Hypertensive Pediatric Data across Sponsors using SAS and the CDISC Model Julie Maddox, SAS Institute,

More information

Study Data Reviewer s Guide Completion Guideline

Study Data Reviewer s Guide Completion Guideline Study Data Reviewer s Guide Completion Guideline 22-Feb-2013 Revision History Date Version Summary 02-Nov-2012 0.1 Draft 20-Nov-2012 0.2 Added Finalization Instructions 10-Jan-2013 0.3 Updated based on

More information

Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team

Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team Notes to Readers This Implementation Guide is version 1.1 and corresponds to Version 2.1 of the

More information

Implementing CDISC Using SAS. Full book available for purchase here.

Implementing CDISC Using SAS. Full book available for purchase here. Implementing CDISC Using SAS. Full book available for purchase here. Contents About the Book... ix About the Authors... xv Chapter 1: Implementation Strategies... 1 The Case for Standards... 1 Which Models

More information

What is high quality study metadata?

What is high quality study metadata? What is high quality study metadata? Sergiy Sirichenko PhUSE Annual Conference Barcelona, 2016 What is study metadata? Trial Design domains Reviewer s Guides acrf Define.xml Conclusion Topics What is study

More information

Data Integrity through DEFINE.PDF and DEFINE.XML

Data Integrity through DEFINE.PDF and DEFINE.XML Data Integrity through DEFINE.PDF and DEFINE.XML Sy Truong, Meta Xceed, Inc, Fremont, CA ABSTRACT One of the key questions asked in determining if an analysis dataset is valid is simply, what did you do

More information

The application of SDTM in a disease (oncology)-oriented organization

The application of SDTM in a disease (oncology)-oriented organization Paper CD01 The application of SDTM in a disease (oncology)-oriented organization Angelo Tinazzi, Alessandro Cattaneo, Enrica Paschetto, Sonia Colombini SENDO-Tech S.r.l., Milan, Italy ABSTRACT Applying

More information

Introduction to Define.xml

Introduction to Define.xml Introduction to Define.xml Bay Area CDISC Implementation Network 4 April 2008 John Brega, PharmaStat LLC Presentation Objectives 1. Introduce the concept and purpose of define.xml 2. Introduce the published

More information

Metadata and ADaM.

Metadata and ADaM. Metadata and ADaM 1 Disclaimer Any views or opinions presented in this presentation are solely those of the author and do not necessarily represent those of the company. 2 Agenda Introduction of ADaM Metadata

More information

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania PharmaSUG 2014 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data

More information

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Paper CD02 SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Brian Mabe, UCB Biosciences, Raleigh, USA ABSTRACT Many pharmaceutical companies are now entrenched

More information

Prove It! Importance and Methodologies of Validation in Clinical Trials Reporting

Prove It! Importance and Methodologies of Validation in Clinical Trials Reporting MEDICAL WRITING CLINICAL PROGRAMMING BIOSTATISTICS DATA MANAGEMENT REGULATORY AFFAIRS MEDICAL INFORMATION Prove It! Importance and Methodologies of Validation in Clinical Trials Reporting Michigan SAS

More information

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes ABSTRACT PharmaSUG 2014 PO16 Automation of ADAM set Creation with a Retrospective, Prospective and Pragmatic Process Karin LaPann, MSIS, PRA International, USA Terek Peterson, MBA, PRA International, USA

More information

Dataset-XML - A New CDISC Standard

Dataset-XML - A New CDISC Standard Dataset-XML - A New CDISC Standard Lex Jansen Principal Software Developer @ SAS CDISC XML Technologies Team Single Day Event CDISC Tools and Optimization September 29, 2014, Cary, NC Agenda Dataset-XML

More information

Adding, editing and managing links to external documents in define.xml

Adding, editing and managing links to external documents in define.xml SDTM-ETL 3.1 User Manual and Tutorial Author: Jozef Aerts, XML4Pharma Last update: 2015-05-25 Adding, editing and managing links to external documents in define.xml Define.xml contains the metadata of

More information

CBER STUDY DATA STANDARDS UPDATE

CBER STUDY DATA STANDARDS UPDATE CBER STUDY DATA STANDARDS UPDATE Lisa Lin, MBA Study Data Standards Manager Office of the Director Center for Biologics Evaluation and Research U.S. Food & Drug Administration PhUSE US Connect Raleigh,

More information

Robust approach to create Define.xml v2.0. Vineet Jain

Robust approach to create Define.xml v2.0. Vineet Jain Robust approach to create Define.xml v2.0 Vineet Jain DEFINE SYSTEM GOALS Generic Powerful Reliable Integrable Efficient Works across SDTM, ADaM & SEND Create define.xml, annotated CRF & define.pdf Create

More information

Reporting & Visualisation : D un Dun standard maison au format CDISC 02/02/2016 CDISC GUF 1

Reporting & Visualisation : D un Dun standard maison au format CDISC 02/02/2016 CDISC GUF 1 Reporting & Visualisation : D un Dun standard maison au format CDISC Jérémy MAMBRINI Florence WAGER 02/02/2016 CDISC GUF 1 Contents CDISC Implementation ti at SERVIER Reporting & Visualisation using CDISC

More information

A Practical and Efficient Approach in Generating AE (Adverse Events) Tables within a Clinical Study Environment

A Practical and Efficient Approach in Generating AE (Adverse Events) Tables within a Clinical Study Environment A Practical and Efficient Approach in Generating AE (Adverse Events) Tables within a Clinical Study Environment Abstract Jiannan Hu Vertex Pharmaceuticals, Inc. When a clinical trial is at the stage of

More information

THE DATA DETECTIVE HINTS AND TIPS FOR INDEPENDENT PROGRAMMING QC. PhUSE Bethan Thomas DATE PRESENTED BY

THE DATA DETECTIVE HINTS AND TIPS FOR INDEPENDENT PROGRAMMING QC. PhUSE Bethan Thomas DATE PRESENTED BY THE DATA DETECTIVE HINTS AND TIPS FOR INDEPENDENT PROGRAMMING QC DATE PhUSE 2016 PRESENTED BY Bethan Thomas What this presentation will cover And what this presentation will not cover What is a data detective?

More information

Legacy to SDTM Conversion Workshop: Tools and Techniques

Legacy to SDTM Conversion Workshop: Tools and Techniques Legacy to SDTM Conversion Workshop: Tools and Techniques Mike Todd President Nth Analytics Legacy Data Old studies never die Legacy studies are often required for submissions or pharmacovigilence. Often

More information

CDISC SDTM and ADaM Real World Issues

CDISC SDTM and ADaM Real World Issues CDISC SDTM and ADaM Real World Issues Washington DC CDISC Data Standards User Group Meeting Sy Truong President MXI, Meta-Xceed, Inc. http://www.meta-x.com Agenda CDISC SDTM and ADaM Fundamentals CDISC

More information

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit Lex Jansen Principal Software Developer @ SAS PharmaSUG 2016 Agenda Why Analysis Results Metadata?

More information

Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database

Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database PharmaSUG 2017 - Paper DS13 Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database ABSTRACT Cori Kramer, Ragini Hari, Keith Shusterman, Chiltern When SDTM

More information

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting CDASH Standards and EDC CRF Library Guang-liang Wang September 18, 2014 2014 Q3 DCDISC Meeting 1 Disclaimer The content of this presentation does not represent the views of my employer or any of its affiliates.

More information